Moray Medical, a Mountain View, Calif.-based interventional robotics startup, raised $3.3m in seed funding.
The round was led by 415 Capital with participation from other medtech entrepreneurs. In conjunction with the funding, 415 Capital’s Senior Venture Partner, Dr. Azin Parhizgar, joined Moray’s Board of Directors.
Led by Mark Barrish, CEO and Co-Founder, Moray is developing the CoralTMsystem, a novel interventional robotics platform powered by microfluidics and an augmented reality (AR) digital user interface. While the platform can have application to simplify a wide range of minimally invasive cardiovascular interventions, Moray is initially focused on the transcatheter mitral valve repair (TMVR) market.